This is a complete emotional reaction - unless you
Post# of 148170
Folks - there is the science of Leronlimab and there is the buisness of Cytodyn. While those two are connected, don’t confuse the two. Let Nader and team do their jobs. The reality is no one on this board knows why that buisness decision was made - it doesn’t change the science of Leronlimab, it doesn’t change the trial outcomes, it doesn’t change the uplisting, —- accept it and move on.